-
1
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
2
-
-
33947687854
-
Inflammation in prostate carcinogenesis
-
De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7: 256-69.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 256-269
-
-
De Marzo, A.M.1
Platz, E.A.2
Sutcliffe, S.3
Xu, J.4
Gronberg, H.5
Drake, C.G.6
-
3
-
-
70449526643
-
Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate
-
Elkahwaji JE, Hauke RJ, Brawner CM. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. Br J Cancer 2009;101:1740-8.
-
(2009)
Br J Cancer
, vol.101
, pp. 1740-1748
-
-
Elkahwaji, J.E.1
Hauke, R.J.2
Brawner, C.M.3
-
4
-
-
84255212972
-
Acute bacterial inflammation of the mouse prostate
-
BoehmBJ,ColopySA, Jerde TJ, LoftusCJ,BushmanW. Acute bacterial inflammation of the mouse prostate. Prostate 2012;72:307-17.
-
(2012)
Prostate
, vol.72
, pp. 307-317
-
-
Boehm, B.J.1
Colopy, S.A.2
Jerde, T.J.3
Loftus, C.J.4
Bushman, W.5
-
5
-
-
0346656567
-
Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate
-
Royuela M, Ricote M, Parsons MS, García-Tuñon I, Paniagua R, De Miguel MP. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. J Pathol 2004;202:41-9.
-
(2004)
J Pathol
, vol.202
, pp. 41-49
-
-
Royuela, M.1
Ricote, M.2
Parsons, M.S.3
García-Tuñon, I.4
Paniagua, R.5
De Miguel, M.P.6
-
6
-
-
0041677606
-
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
-
Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20.
-
(2003)
Biochem J
, vol.374
, pp. 1-20
-
-
Heinrich, P.C.1
Behrmann, I.2
Haan, S.3
Hermanns, H.M.4
Muller-Newen, G.5
Schaper, F.6
-
7
-
-
0032880248
-
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer
-
Drachenberg DE, Elgamal AA, RowbothamR, Peterson M, Murphy GP. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999;41:127-33.
-
(1999)
Prostate
, vol.41
, pp. 127-133
-
-
Drachenberg, D.E.1
Elgamal, A.A.2
Rowbotham, R.3
Peterson, M.4
Murphy, G.P.5
-
8
-
-
0032830265
-
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma
-
Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol 1999;161:182-7.
-
(1999)
J Urol
, vol.161
, pp. 182-187
-
-
Adler, H.L.1
McCurdy, M.A.2
Kattan, M.W.3
Timme, T.L.4
Scardino, P.T.5
Thompson, T.C.6
-
10
-
-
0035992415
-
Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells
-
Godoy-Tundidor S, Hobisch A, Pfeil K, Bartsch G, Culig Z. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells. Clin Cancer Res 2002;8: 2356-61.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2356-2361
-
-
Godoy-Tundidor, S.1
Hobisch, A.2
Pfeil, K.3
Bartsch, G.4
Culig, Z.5
-
11
-
-
33645514605
-
Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice
-
Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, et al. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Cancer Res 2006;66:3087-95.
-
(2006)
Cancer Res
, vol.66
, pp. 3087-3095
-
-
Wallner, L.1
Dai, J.2
Escara-Wilke, J.3
Zhang, J.4
Yao, Z.5
Lu, Y.6
-
12
-
-
83255176682
-
Randomised phase II study of siltuximab (CNTO 328), an anti- IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
-
Fizazi K, De Bono JS, Flechon A, Heidenreich A, Voog E, Davis NB, et al. Randomised phase II study of siltuximab (CNTO 328), an anti- IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer. Eur J Cancer 2012;48:85-93.
-
(2012)
Eur J Cancer
, vol.48
, pp. 85-93
-
-
Fizazi, K.1
De Bono, J.S.2
Flechon, A.3
Heidenreich, A.4
Voog, E.5
Davis, N.B.6
-
13
-
-
77954069855
-
Isolation, cultivation and characterization of adult murine prostate stem cells
-
Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON. Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 2010;5:702-13.
-
(2010)
Nat Protoc
, vol.5
, pp. 702-713
-
-
Lukacs, R.U.1
Goldstein, A.S.2
Lawson, D.A.3
Cheng, D.4
Witte, O.N.5
-
14
-
-
77955121375
-
Identification of a cell of origin for human prostate cancer
-
Goldstein AS, Huang J, Guo C, Garraway IP,Witte ON. Identification of a cell of origin for human prostate cancer. Science 2010;329: 568-71.
-
(2010)
Science
, vol.329
, pp. 568-571
-
-
Goldstein, A.S.1
Huang, J.2
Guo, C.3
Garraway, I.P.4
Witte, O.N.5
-
15
-
-
79956126860
-
IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR
-
Rojas A, Liu G, Coleman I, Nelson PS, Zhang M, Dash R, et al. IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene 2011;30:2345-55.
-
(2011)
Oncogene
, vol.30
, pp. 2345-2355
-
-
Rojas, A.1
Liu, G.2
Coleman, I.3
Nelson, P.S.4
Zhang, M.5
Dash, R.6
-
16
-
-
81155132204
-
C-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M
-
Kan CE, Cipriano R, Jackson MW. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M. Cancer Res 2011;71:6930-9.
-
(2011)
Cancer Res
, vol.71
, pp. 6930-6939
-
-
Kan, C.E.1
Cipriano, R.2
Jackson, M.W.3
-
17
-
-
0034721080
-
Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells
-
Klausen P, Pedersen L, Jurlander J, Baumann H. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene 2000;19:3675-83.
-
(2000)
Oncogene
, vol.19
, pp. 3675-3683
-
-
Klausen, P.1
Pedersen, L.2
Jurlander, J.3
Baumann, H.4
-
18
-
-
33645920300
-
PI3K/Akt signaling regulates p27kip1 expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27kip1 regulation in LNCaP and PC346 cells
-
Van Duijn PW, Trapman J. PI3K/Akt signaling regulates p27kip1 expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27kip1 regulation in LNCaP and PC346 cells. Prostate 2006;66:749-60.
-
(2006)
Prostate
, vol.66
, pp. 749-760
-
-
Van Duijn, P.W.1
Trapman, J.2
-
19
-
-
0036847690
-
Elevated Skp2 protein expression in human prostate cancer association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival
-
Yang G, Ayala G, Marzo AD, Tian W, Frolov A, Wheeler TM, et al. Elevated Skp2 protein expression in human prostate cancer association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res 2002; 8:3419-26.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3419-3426
-
-
Yang, G.1
Ayala, G.2
Marzo, A.D.3
Tian, W.4
Frolov, A.5
Wheeler, T.M.6
-
20
-
-
84255199166
-
Molecular genetics of prostate cancer: Emerging appreciation of genetic complexity
-
Barbieri CE, Demichelis F, Rubin MA. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Histopathology 2012;60:187-98.
-
(2012)
Histopathology
, vol.60
, pp. 187-198
-
-
Barbieri, C.E.1
Demichelis, F.2
Rubin, M.A.3
|